Home / Stocks / MS

Morgan Stanley (MS, Brokers & investment banks) Stock Valuation & Fair Value Mixed on our tests

Morgan Stanley (MS, Brokers & investment banks) trades at a current P/E of 15.6, about 16% above its historical normal valuation, with a forward growth estimate of 9.9% and a PEG of 1.58. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 13.5 on the same blended earnings, the 2026-10-09 close of $190.02 corresponds to about $164 a share. This is a valuation reference, not a price target.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.

DATA AS OF 2026-10-12
Current P/E
15.6
Normal P/E
13.5
PEG
1.58
Fwd growth
9.9%
Div yield
2.4%
RSI (14)
34.2
Neutral
Technical context
  • Price $190.02 at the 2026-10-12 close, 2.6% below the 20-day average ($195.17) and 8.2% below the 50-day ($206.92).
  • RSI (14) at 34.2.
  • 52-week range $151.69 to $227.30: the price is 16.4% below the high and 25.3% above the low.

The Street vs SeerForecast

Wall Street's mean price target for MS is $223.41 across 22 analysts, 17.6% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from trading above its usual valuation (2026-06-03) to mixed on our tests (2026-10-12).

Current P/E and rating by weekCurrent P/E moved from 18.7 to 15.6 between 2026-06-03 and 2026-10-09, against a normal P/E of 13.5, with 3 rating changes over 39 recorded weeks.2026-06-03: P/E 18.7, Trading above its usual valuation, recalculated for the week of 2026-06-032026-06-10: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-06-102026-06-12: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-06-142026-06-16: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-06-162026-06-18: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-06-212026-07-02: P/E 19.1, Significantly overvalued, recalculated for the week of 2026-07-022026-07-06: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-07-062026-07-09: P/E 19.3, Significantly overvalued, recalculated for the week of 2026-07-092026-07-10: P/E 19.9, Significantly overvalued, recalculated for the week of 2026-07-122026-07-13: P/E 19.9, Significantly overvalued, recalculated for the week of 2026-07-132026-07-14: P/E 19.9, Significantly overvalued, recalculated for the week of 2026-07-142026-07-20: P/E 18.5, Trading above its usual valuation, recalculated for the week of 2026-07-202026-07-22: P/E 18.5, Trading above its usual valuation, recalculated for the week of 2026-07-222026-07-24: P/E 18.4, Trading above its usual valuation, recalculated for the week of 2026-07-252026-07-27: P/E 18.4, Trading above its usual valuation, recalculated for the week of 2026-07-272026-07-31: P/E 17.9, Trading above its usual valuation, recalculated for the week of 2026-07-312026-07-31: P/E 17.9, Trading above its usual valuation, recorded live 2026-08-032026-08-07: P/E 18.1, Trading above its usual valuation, recalculated for the week of 2026-08-072026-08-07: P/E 18.4, Trading above its usual valuation, recorded live 2026-08-102026-08-14: P/E 18.5, Trading above its usual valuation, recalculated for the week of 2026-08-142026-08-14: P/E 18.4, Trading above its usual valuation, recorded live 2026-08-172026-08-21: P/E 17.5, Trading above its usual valuation, recalculated for the week of 2026-08-212026-08-21: P/E 18.0, Trading above its usual valuation, recorded live 2026-08-242026-08-27: P/E 18.0, Trading above its usual valuation, recalculated for the week of 2026-08-272026-08-28: P/E 18.0, Trading above its usual valuation, recalculated for the week of 2026-08-282026-08-28: P/E 18.0, Trading above its usual valuation, recalculated for the week of 2026-08-302026-08-28: P/E 18.0, Trading above its usual valuation, recorded live 2026-08-312026-09-04: P/E 18.2, Trading above its usual valuation, recalculated for the week of 2026-09-052026-09-04: P/E 18.2, Trading above its usual valuation, recorded live 2026-09-072026-09-11: P/E 17.8, Trading above its usual valuation, recalculated for the week of 2026-09-122026-09-11: P/E 17.8, Trading above its usual valuation, recorded live 2026-09-142026-09-18: P/E 16.8, Trading above its usual valuation, recalculated for the week of 2026-09-192026-09-18: P/E 16.8, Trading above its usual valuation, recorded live 2026-09-212026-09-25: P/E 16.2, Trading above its usual valuation, recalculated for the week of 2026-09-262026-09-25: P/E 16.2, Trading above its usual valuation, recorded live 2026-09-282026-10-02: P/E 15.6, Mixed on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 15.6, Mixed on our tests, recorded live 2026-10-052026-10-09: P/E 15.6, Mixed on our tests, recalculated for the week of 2026-10-102026-10-09: P/E 15.6, Mixed on our tests, recorded live 2026-10-1214.016.018.0Jun 3Jul 5Aug 6Sep 7Oct 9Normal P/E 13.5
Mixed on our testsTrading above its usual valuationSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 18.7+39%Trading above its usual valuation (recalculated)
2026-06-10P/E 19.3+44%Significantly overvalued (recalculated)
2026-07-12P/E 19.9+48%Significantly overvalued (recalculated)
2026-07-20P/E 18.5+38%Trading above its usual valuation (recalculated)
2026-10-03P/E 15.6+16%Mixed on our tests (recalculated)
2026-10-10P/E 15.6+16%Mixed on our tests (recalculated)
2026-10-12P/E 15.6+16%Mixed on our tests ← now
Show all 39 weeks
WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 18.7+39%Trading above its usual valuation (recalculated)
2026-06-10P/E 19.3+44%Significantly overvalued (recalculated)
2026-06-14P/E 19.3+44%Significantly overvalued (recalculated)
2026-06-16P/E 19.3+44%Significantly overvalued (recalculated)
2026-06-21P/E 19.3+44%Significantly overvalued (recalculated)
2026-07-02P/E 19.1+42%Significantly overvalued (recalculated)
2026-07-06P/E 19.3+43%Significantly overvalued (recalculated)
2026-07-09P/E 19.3+43%Significantly overvalued (recalculated)
2026-07-12P/E 19.9+48%Significantly overvalued (recalculated)
2026-07-13P/E 19.9+48%Significantly overvalued (recalculated)
2026-07-14P/E 19.9+48%Significantly overvalued (recalculated)
2026-07-20P/E 18.5+38%Trading above its usual valuation (recalculated)
2026-07-22P/E 18.5+38%Trading above its usual valuation (recalculated)
2026-07-25P/E 18.4+36%Trading above its usual valuation (recalculated)
2026-07-27P/E 18.4+36%Trading above its usual valuation (recalculated)
2026-07-31P/E 17.9+33%Trading above its usual valuation (recalculated)
2026-08-03P/E 17.9+33%Trading above its usual valuation
2026-08-07P/E 18.1+35%Trading above its usual valuation (recalculated)
2026-08-10P/E 18.4+36%Trading above its usual valuation
2026-08-14P/E 18.5+37%Trading above its usual valuation (recalculated)
2026-08-17P/E 18.4+36%Trading above its usual valuation
2026-08-21P/E 17.5+30%Trading above its usual valuation (recalculated)
2026-08-24P/E 18.0+34%Trading above its usual valuation
2026-08-27P/E 18.0+34%Trading above its usual valuation (recalculated)
2026-08-28P/E 18.0+34%Trading above its usual valuation (recalculated)
2026-08-30P/E 18.0+34%Trading above its usual valuation (recalculated)
2026-08-31P/E 18.0+34%Trading above its usual valuation
2026-09-05P/E 18.2+35%Trading above its usual valuation (recalculated)
2026-09-07P/E 18.2+35%Trading above its usual valuation
2026-09-12P/E 17.8+32%Trading above its usual valuation (recalculated)
2026-09-14P/E 17.8+32%Trading above its usual valuation
2026-09-19P/E 16.8+24%Trading above its usual valuation (recalculated)
2026-09-21P/E 16.8+24%Trading above its usual valuation
2026-09-26P/E 16.2+20%Trading above its usual valuation (recalculated)
2026-09-28P/E 16.2+20%Trading above its usual valuation
2026-10-03P/E 15.6+16%Mixed on our tests (recalculated)
2026-10-05P/E 15.6+16%Mixed on our tests
2026-10-10P/E 15.6+16%Mixed on our tests (recalculated)
2026-10-12P/E 15.6+16%Mixed on our tests ← now

Frequently asked questions

Is Morgan Stanley stock overvalued?

At a current P/E of 15.6 versus its historical normal P/E of 13.5, Morgan Stanley trades about 16% above its typical valuation, with a PEG of 1.58 on 9.9% forward growth. tickerseer currently rates it mixed on our tests.

What is Morgan Stanley's fair value and PEG?

Morgan Stanley trades at a current P/E of 15.6 against a historical normal P/E of 13.5, a PEG of 1.58, and a forward growth estimate of 9.9%. Priced at its historical normal P/E of 13.5 on the same blended earnings, the 2026-10-09 close of $190.02 corresponds to about $164 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Morgan Stanley changed?

tickerseer's rating moved from trading above its usual valuation (2026-06-03) to mixed on our tests (2026-10-12).

What is the analyst price target for Morgan Stanley?

The mean Wall Street price target for Morgan Stanley is $223.41 across 22 analysts, 17.6% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Brokers & investment banks. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track MS free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.